Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

449
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
449
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.2K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.2K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined large and small airway obstruction is associated with increased exacerbation frequency and poorer symptom control in persistent asthma.

The journal of allergy and clinical immunology. In practice·2026
Same author

Biomarkers for COPD with Type 2 Inflammation.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Prioritising efficacy over convenience.

American journal of respiratory and critical care medicine·2026
Same author

Single-cell transcriptomics of granulocytes in asthma and atopic diseases.

Frontiers in molecular biosciences·2026
Same author

Tezepelumab in Real-World U.S. Patients with Severe Asthma Across Phenotypes and Underrepresented Populations: The Phase 4 PASSAGE Study.

American journal of respiratory and critical care medicine·2026
Same author

Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.

Nature medicine·2026

Related Experiment Video

Updated: Jul 23, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K

Asthma Exacerbations: Patient Features and Potential Long-Term Implications.

Praveen Akuthota1

  • 1Division of Pulmonary, Critical Care, Sleep Medicine, & Physiology, University of California San Diego, La Jolla, CA, USA. pakuthota@health.ucsd.edu.

Advances in Experimental Medicine and Biology
|July 18, 2023
PubMed
Summary

Asthma exacerbations are triggered by viral infections and environmental exposures, influenced by host factors like type II inflammation and genetics. Early intervention and understanding these triggers are key to preventing future asthma attacks and preserving lung health.

Keywords:
AllergensAnti-viral immunityCOVIDEnvironmental exposuresExacerbationsExposuresHeterogeneityInfectionRemodelingRespiratory virusRhinovirus

More Related Videos

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.7K
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

740

Related Experiment Videos

Last Updated: Jul 23, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.7K
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

740

Area of Science:

  • Pulmonology and immunology
  • Environmental health
  • Genetics

Background:

  • Asthma exacerbations result from complex interactions between external triggers and individual host factors.
  • Viral infections, especially rhinovirus, and environmental exposures like allergens are primary initiators of asthma attacks.
  • Underlying type II inflammation is a significant factor in exacerbation risk and severity.

Purpose of the Study:

  • To elucidate the multifactorial nature of asthma exacerbations.
  • To highlight the roles of viral infections, environmental exposures, type II inflammation, and genetic predisposition.
  • To underscore the predictive value of exacerbation history on long-term lung health.

Main Methods:

  • Review and synthesis of existing research on asthma exacerbation triggers and risk factors.
  • Analysis of the interplay between environmental exposures, host genetics, and inflammatory pathways.
  • Examination of clinical data linking exacerbation history to long-term outcomes.

Main Results:

  • Viral infections and environmental exposures are dominant triggers for asthma exacerbations.
  • Type II inflammation, indicated by specific biomarkers, significantly drives exacerbation risk and is targeted by effective biologics.
  • Genetic polymorphisms, while individually minor, collectively increase exacerbation risk, particularly when combined with environmental factors.
  • A history of asthma exacerbations is a strong predictor of future events and potential long-term lung damage.

Conclusions:

  • Asthma exacerbations are multifactorial, involving a complex interplay of infections, environmental exposures, host genetics, and inflammation.
  • Targeting type II inflammation pathways with biologics effectively reduces exacerbations.
  • Understanding individual risk factors, including genetic predisposition and past exacerbation history, is crucial for managing asthma and preventing long-term lung health decline.